Published · Last updated
Tesamorelin is a man-made version of growth hormone-releasing hormone (GHRH). It has been studied in adults with HIV-related fat build-up around the stomach. That research does not show it is suitable for general weight loss or personal use.
This guide covers:
- What the evidence shows
- How it compares with Sermorelin and CJC-1295
- The rules that apply to it
- Why 30-day stories and dissolving tests prove little
It also answers common questions. It does not recommend where to buy it or explain how to use it.
What is Tesamorelin, and what has it been studied for?
Tesamorelin is a GHRH analogue. GHRH stands for growth hormone-releasing hormone. The name describes a signalling pathway in the body. It is not a promise about weight, muscle or performance.
In the US, the FDA prescribing information for EGRIFTA WR covers one use only: reducing excess stomach fat in adults with HIV-related lipodystrophy. It clearly states it is not for general weight loss.
That approval applies to one prescription medicine for one use. It does not cover other products sold under the same name.
A compound name is not a medicine
A medicine label names a specific formula, what it is for and the evidence behind it. Seeing the same compound name on another product tells you nothing about:
- How it was made
- Whether it is safe
- Whether it is suitable for medical use
The prescribing information also lists risks. These include raised IGF-1, fluid retention, problems handling blood sugar and allergic reactions. Personal treatment decisions need a qualified doctor. This guide aims only to help you read the research correctly.
How does Tesamorelin compare with Sermorelin and CJC-1295 with Ipamorelin?
Don’t start by asking which peptide is “strongest”. Start with what each one is and what evidence exists.
These compounds are often grouped together online. But that grouping can hide the fact that they work in different ways and were studied in different ways.
| Compound | Research context | What to check |
|---|---|---|
| Tesamorelin | GHRH analogue. Studied in HIV-related stomach fat build-up. | Who was studied, which formula and what was measured. |
| Sermorelin | A GHRH fragment, often called GRF 1–29. | Its exact identity. Don’t assume it equals Tesamorelin. |
| CJC-1295 | GHRH analogue. Published work includes a long-acting form. | “DAC” vs “without DAC” naming, and which compound was actually studied. |
| Ipamorelin | Growth hormone releaser that works through a different receptor. | Whether the evidence is for Ipamorelin alone or a named combination. |
Why does DAC terminology matter?
A study on long-acting CJC-1295 is not proof for a product sold as “CJC-1295 without DAC”. Always check which compound was used before applying a study’s results to another formula. Our CJC-1295 guide to DAC and no-DAC terminology explains the difference.
Does combining two peptides prove better results?
No. How a compound works can raise a research question. But to claim better results, you need proper head-to-head evidence. Look for:
- A direct comparison
- A clear outcome being measured
- A long enough follow-up
A change in one hormone level does not, on its own, show long-term benefit or safety.
What can Tesamorelin results after 30 days really tell you?
A 30-day diary can be interesting, but it does not prove much. The video “I Tried Tesamorelin for 30 Days (Labwork and DEXA Scan)” is one person’s story. We are not presenting it as our own experience. We are also not repeating unchecked before-and-after numbers.
Compare that with a randomised Tesamorelin study published in the New England Journal of Medicine:
- It included 412 patients with HIV and stomach fat build-up.
- It ran for 26 weeks.
- Its main outcome was deep belly (visceral) fat, measured by CT scan.
Who was studied, for how long and how results were measured all matter when reading the findings.
A DEXA scan, a blood test and a CT result are not the same kind of evidence. Before comparing them, ask what each one measured and whether conditions were similar.
Use this quick checklist for any results claim:
- Starting point: Are starting measurements and background given?
- Other changes: Did diet, training, medicines or anything else change too?
- Measurement: Was the same method used under similar conditions?
- Comparison: Is there a control group, or just one person’s timeline?
- Scope: Does the conclusion stick to what was measured?
A before-and-after change can raise a useful question. It cannot prove what caused the change. It also cannot predict what will happen to someone else.
What does a Tesamorelin dissolution test actually prove?
A video of powder dissolving shows only that sample in those conditions. It does not prove what the substance is or how much Tesamorelin it contains. A clear liquid does not prove purity, stability or sterility.
We searched for the “Tesamorelin 20mg Dissolution test Liu0805” claim. We could not find an original lab report that matches it. Without that report and the sample details, it cannot be used as evidence about any other sample.
What documentation is more useful?
Ask for:
- The batch number
- The lab’s name
- The test method used
- The result reported
Identity, HPLC purity and total peptide content answer different questions. A good report makes clear which of these was measured.
Our guide to peptide purity, HPLC and Certificates of Analysis explains the differences. A lab report only applies to the sample and batch named in it. A generic sample report says nothing about other material.
What is the regulatory context for Tesamorelin?
Approval in one country does not mean approval in another. An approved use also does not cover every other use.
The US prescribing information above covers one named medicine for one patient group. It is not permission to get or use research-labelled material.
The European Medicines Agency records that the Egrifta marketing-authorisation application was withdrawn in 2012. This is a historical record. It is not a full statement of current UK law. It also does not mean that owning, researching or accessing it in a clinic all have the same legal status.
In the UK, MHRA guidance addresses the restricted supply of unlicensed medicinal products. These rules are not an invitation to source or use a compound yourself. A healthcare professional must assess personal medical questions. Legal questions need advice for the specific product and situation.
Does a “research use only” label establish safety?
No. A research label does not show that material is safe for people to use. It does not replace the rules that apply to medicines.
A lab result also does not show that a person can safely use the material. Lab testing, clinical evidence and regulatory approval each answer different questions.
This article does not recommend buying Tesamorelin. It does not compare suppliers or give prices, doses or injection instructions.
Tesamorelin frequently asked questions
Tesamorelin vs Sermorelin vs CJC-1295 with Ipamorelin?
Tesamorelin and Sermorelin are GHRH-related peptides. CJC-1295 is another GHRH analogue, while Ipamorelin acts through a different growth-hormone secretagogue pathway. Comparing them requires the exact compound, formulation and study population. A shared connection to growth hormone does not establish equivalent results, safety or suitability for a particular person.
Tesamorelin (subcutaneous route)?
Subcutaneous means beneath the skin. It is the administration route specified for the prescription Tesamorelin medicine EGRIFTA WR. That prescribing information applies to its named formulation, not every vial labelled Tesamorelin. A research-product listing is not an injection guide; questions about treatment belong with a qualified prescribing clinician.
Tesamorelin 20mg Dissolution test Liu0805?
We could not verify a primary laboratory report matching this exact title. If it refers to a dissolution video, visible dissolving alone cannot confirm Tesamorelin identity, purity, peptide content or sterility. Request a batch-matched report describing the sample, analytical methods, results and testing laboratory before drawing conclusions.
Tesamorelin vs CJC-1295?
Both are discussed as GHRH analogues, but they are distinct compounds with different research histories. CJC-1295 comparisons also need to distinguish DAC terminology from listings described as without DAC. Evidence about one molecule or formulation should not be transferred to another, and hormone measurements alone do not establish comparable clinical outcomes.
I Tried Tesamorelin for 30 Days (Labwork and DEXA Scan)?
This is the title of a personal-experience video, not a controlled clinical trial. Before-and-after blood tests and DEXA scans can document changes in one person, but cannot isolate Tesamorelin from diet, exercise, other interventions or measurement variation. They should not be treated as a forecast of your own results.
How Much Does Tesamorelin Cost?
Costs quoted online can refer to different formulations, jurisdictions and services, so they are not a reliable guide to lawful or appropriate access. This educational article does not provide prices or purchasing recommendations. Questions about any clinically appropriate treatment and its costs should be discussed with a qualified healthcare professional.
How should you interpret the evidence?
When reading any Tesamorelin claim, check:
- The exact compound
- The formula
- Who was studied
- What was measured
A personal story cannot prove cause and effect. A dissolving test cannot prove identity, purity or safety for human use.
Use the linked sources to see what was actually studied. If this relates to your own health, speak to a qualified healthcare professional. Do not use online research summaries to plan treatment.